Skip to main content
SpringerLink
Log in

Krebs und Hormone

  • Chapter
Book cover Die Gynäkologie

  • 2097 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Al-Azzawi F, Alt J, Aso T et al. (2001) Hormone replacement therapy and cancer. Climacteric 4: 181–193

    Google Scholar 

  • Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G (1999) Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46,000 women from Royal College of General Practitioners’ oral contraception study. Br Med J 318(7176): 96–100

    CAS  Google Scholar 

  • Birkhäuser M, Braendle W, Keller PJ, Kiesel L, Kuhl H, Neulen J (2004) Empfehlungen zur Substitution mit Estrogenen und Gestagenen im Klimakterium und in der Postmenopause. 31. Arbeitstreffen des „Zürcher Gesprächskreises“ Oktober 2003. J Menopause 2: 28–36

    Google Scholar 

  • Black WC, Welch HG (1993) Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 328: 1237–1243

    Article  PubMed  CAS  Google Scholar 

  • Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P et al. (1997) Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52: 750–758

    Google Scholar 

  • Bush TL, Whiteman M, Flaws JA (2001) Hormone replacement therapy and breast cancer: a qualitative review. Obstet Gynecol 98: 498–508

    Article  PubMed  CAS  Google Scholar 

  • Chlebowski RT, Hendrix SL, Langer RD et al. (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women’s Health Initiative randomized trial. JAMA 289: 3243–3253

    Article  PubMed  CAS  Google Scholar 

  • Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713–1727

    Article  Google Scholar 

  • Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047–1059

    Article  Google Scholar 

  • Czernobilsky B, Lifschitz-Mercer B (1997) Endometrial pathology. Curr Opin Obstet Gynecol 9: 52–56

    PubMed  CAS  Google Scholar 

  • Fuqua SA, Schiff R, Parra I, Moore JT, Mohsin SK, Osborne CK, Clark GM, Allred DC (2003) Estrogen receptor b protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res 63: 2434–2439

    PubMed  CAS  Google Scholar 

  • Gambrell RD (1997) Strategies to reduce the incidence of endometrial cancer in postmenopausal women. Am J Obstet Gynecol 177: 1196–1207

    Article  PubMed  Google Scholar 

  • Harding C, Knox WF, Faragher EB, Baildam A, Bundred NJ (1996) Hormone replacement therapy and tumor grade in breast cancer: prospective study in screening unit. Br Med J 312: 1646–1647

    CAS  Google Scholar 

  • Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ (1999) Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 84: 4559–4565

    Article  PubMed  CAS  Google Scholar 

  • Kommission „Hormontoxikologie“ der Deutschen Gesellschaft für Endokrinologie (2000) Karzinogene Eigenschaften von Estradiol-17β. Endokrinol Inf 24: 181–186

    Google Scholar 

  • Kuhl H (1998) Hormonsubstitution und Mammakarzinomrisiko: Haben Gestagene einen protektiven Effekt? Frauenarzt 39

    Google Scholar 

  • Kuhl H (2004) Is the elevated breast cancer risk observed in the WHI study an artifact? Climacteric 7: 319–322

    Article  PubMed  CAS  Google Scholar 

  • Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138: 863–870

    Article  PubMed  CAS  Google Scholar 

  • Leidenberger F, Strowitzki T, Ortmann O (Hrsg) (2005) Klinische Endokrinologie für Frauenärzte, 3. vollst. überarb. erw. Aufl. Berlin, Heidelberg, New York: Springer

    Google Scholar 

  • Li CI, Malone KE, Porter PL et al. (2003) Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 289: 3254–3263

    Article  PubMed  CAS  Google Scholar 

  • Menard S, Casalini P, Agresti R, Pilotti S, Balsari A (1998) Proliferation of breast carcinoma during menstrual phases. Lancet 352: 148–149

    Article  PubMed  CAS  Google Scholar 

  • Million Women Study Collaborators (2003) Breast cancer and hormonereplacement therapy in the Million Women Study. Lancet 362: 419–427

    Article  CAS  Google Scholar 

  • Murphy LC, Wang M, Coutt A, Dotzlaw H (1996) Novel mutations in the estrogen receptor messenger RNA in human breast cancers. J Clin Endocrinol Metab 81: 1420–1427

    Article  PubMed  CAS  Google Scholar 

  • Musgrove EA, Sutherland RL (1997) Steroidal control of cell proliferation in the breast and breast cancer. In: Wren BG (ed) Progress in the management of the menopause. New York: Parthenon: 194–202

    Google Scholar 

  • Ness RB, Grisso JA, Klapper J, Schlesselman JJ, Silberzweig S, Vergona R, Morgan M, Wheeler JE (2000) Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions. Am J Epidemiol 152(3): 233–241

    Article  PubMed  CAS  Google Scholar 

  • Ortmann O, Diedrich K, Schulz KD (1997) Hormonelle Substitutionstherapie und gynäkologische Malignome. Frauenarzt 38: 1187–1194

    Google Scholar 

  • Ortmann O, Beckmann MW, Diedrich K et al. (2001) Adjuvante Therapie des Mammakarzinoms. Frauenarzt 42, 408–412

    Google Scholar 

  • Persson I, Yuen J, Bergqvist L, Schairer C (1996) Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy — long-term follow-up of a Swedisdh cohort. Int J Cancer 67: 327–332

    Article  PubMed  CAS  Google Scholar 

  • Pike MC, Peters RK, Cozen V, Probst-Hensch N, Wan FJC, Mack M (1997) Estrogen-progestin replacement therapy and endometrial cancer. J Nat Cancer Inst 89: 1110–1116

    Article  PubMed  CAS  Google Scholar 

  • Roger P, Sahla ME, Mäkelä S, Gustafsson JA, Baldet P, Rochefort H (2001) Decreased expression of estrogen receptor b protein in proliferative preinvasive mammary tumors. Cancer Res 61: 2537–2541

    PubMed  CAS  Google Scholar 

  • Russo J, Russo IH (1997) Role of hormones in human breast development: the menopausal breast. In: Wren BG (ed) Progress in the management of the Menopause. New York: Parthenon: 194–202

    Google Scholar 

  • Scheuermann W, Rensing K, Schmid H, Wallwiener D, Bastert G (1997) Mortalität an bösartigen Brust-und Genitaltumoren bei Frauen in der Bundesrepublik Deutschland von 1970–1994. Geburtsh Frauenheilkd 57: 423–428

    Article  Google Scholar 

  • The Women’s Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women’s Health Initiative randomized controlled trial. JAMA 291: 1701–1712

    Article  Google Scholar 

  • Willis DB, Calle EE, Miracle-McMahill HL, Heath CW (1996) Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes Control 7: 449–457

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Gynäkologie und Geburtshilfe, Experimentelle Endokrinologie, Johann Wolfgang Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt

    H. Kuhl (Prof. Dr. med.)

Authors
  1. H. Kuhl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Gynäkologie und Geburtshilfe, Johann Wolfgang Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt

    Manfred Kaufmann (Prof. Dr. med.) (Prof. Dr. med.)

  2. Universitätsfrauenklinik, Otto-von Guericke-Universität Magdeburg, Gerhart-Hauptmann-Straße 35, 39108, Magdeburg

    Serban D. Costa (Prof. Dr. med., Dr. h.-c.) (Prof. Dr. med., Dr. h.-c.)

  3. Frauenklinik, Klinikum St. Marien Amberg, Mariahilfbergweg 7, 92211, Amberg

    Anton Scharl (Prof. Dr. med.) (Prof. Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Kuhl, H. (2006). Krebs und Hormone. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31105-X_32

Download citation

  • DOI: https://doi.org/10.1007/3-540-31105-X_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25664-9

  • Online ISBN: 978-3-540-31105-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation